Category: Blog

Leiden (NL) / Munich (DE) – November 2021 – CellPoint and Hypertrust Patient Data Care (HPDC) today announced the launch of xCellit. The xCellit system was co-developed to make autologous cell therapies available more rapidly and efficiently by facilitating the scheduling, monitoring and data capturing of cell treatment workflows. It is based on HPDC’s X-Chain… Continue reading CellPoint and Hypertrust Patient Data Care co-develop xCellit platform for cell therapies at the point-of-care

Munich (DE) – The development of advanced and personalized therapies, such as Cell & Gene Therapies (also called Advanced Therapy Medicinal Products, ATMPs), brings with it a complexity of patient-specific processes as well as numerous stakeholders, that requires new collaboration paradigms.   For this reason, SAP and Hypertrust Patient Data Care (HPDC) have worked closely… Continue reading Discover how SAP & HPDC used cross-company business workflow to improve transparency in personalized cancer therapies and clinical trials

Basel (CH), Munich (DE), July, 2020 The Digital Incubator Supply Chain team at Roche and Hypertrust Patient Data Care now announced the successful proof of concept for a blockchain-based backbone solution to support the supply chain processes of personalized healthcare (PHC) products.   The solution is based on the innovative Hypertrust Patient Data Care platform… Continue reading Roche and Hypertrust Patient Data Care test blockchain solution for personalized healthcare

Strasbourg (FR) / Munich (DE) – July 9, 2020 –Transgene and Hypertrust Patient Data Care today announced as a world premiere the first productive blockchain solution for clinical trials of personalized healthcare, leveraging the Hypertrust X-Chain for Clinical Trials product. The cloud-based solution monitors and orchestrates the supply chain processes of Transgene’s AI-enhanced TG4050 individualized… Continue reading Transgene and Hypertrust Patient Data Care announce successful go-live of the world’s first blockchain solution for clinical trials of personalized healthcare